Xiaomin Chen was named Chief Executive Officer of Advanced Biomed Inc., effective April 28, 2026. As of November 6, 2026, Advanced Biomed Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from March 30, 2026 to May 1, 2026, naming 2 appointments and 1 departure (Form 8-K, May 1, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Advanced Biomed Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Advanced Biomed Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-03-30 to 2026-05-01. They name 3 people, with 2 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Advanced Biomed Inc. files it.
Also on the record for Advanced Biomed Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 22, 2026 | Stake report, Schedule 13G, by LEE CHEN YI | 7.5% of the class | 5%+ stakes | Source |
| August 20, 2026 | Stake report, Schedule 13G, by Pau Hung To | 12.75% of the class | 5%+ stakes | Source |
| August 20, 2026 | Stake report, Schedule 13G/A, by Pau Hung To | — | 5%+ stakes | Source |
Selling to them or working with them? See who runs Advanced Biomed Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Advanced Biomed Inc. and the records around it.
Advanced Biomed Inc. elsewhere on the record
Watch Advanced Biomed Inc.
Get an email when Advanced Biomed Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Advanced Biomed Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Advanced Biomed Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Advanced Biomed Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-05-01 | In | Chief Executive Officer | 2026-04-28 | 8-K, 2026-05-01 | |
| 2026-03-30 | Out | Chief Technology Officer | 2026-03-25 | 8-K, 2026-03-30 | |
| 2026-03-30 | In | Director | 2026-03-25 | 8-K, 2026-03-30 |
Who leads Advanced Biomed Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Executive Officer: Xiaomin Chen, appointed, effective 2026-04-28 (filed 2026-05-01).
- Director: Mingze Yin, appointed, effective 2026-03-25 (filed 2026-03-30).
- Chief Technology Officer: Fang Cheng, departure reported, effective 2026-03-25 (filed 2026-03-30). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Advanced Biomed Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Executive Officer at Advanced Biomed Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Advanced Biomed Inc.Every change, in the filing's words
Appointed: Xiaomin Chen, Chief Executive Officer, effective 2026-04-28
Upon the recommendation of the Nominating and Corporate Governance Committee, the Board of Directors appointed Mr. Xiaomin Chen as Chief Executive Officer, director and Chairman of the Board of the Company, effective as of April 28, 2026.
- The Company has determined to undertake a significant strategic pivot, transitioning its primary business focus from life sciences to artificial intelligence development (the "Strategic Pivot").
- In light of the Strategic Pivot, the Company and Mr. Yi Lu, the Company's Chief Executive Officer, director and Chairman of the Board, have mutually agreed that a leadership transition is necessary and in the best interests of the Company.
- The separation of Mr. Lu from his position as Chief Executive Officer, director and Chairman of the Board is neither a resignation by Mr. Lu nor a termination by the Company (whether for cause or without cause), but rather represents a mutual agreement between the Company and Mr. Lu to effectuate a leadership transition in connection with the Strategic Pivot (the "Mutual Separation").
- In connection with the Mutual Separation, the Company entered into a termination agreement (the "Termination Agreement"), pursuant to which the Company agreed to issue 39,999 shares of the Company's common stock to Mr. Lu as severance compensation.
- Mr. Xiaomin Chen, age 49, has over 20 years of experience in artificial intelligence, large language models, and financial technology.
Departing: Fang Cheng, Chief Technology Officer, effective 2026-03-25
On March 25, 2026, Steven I-Fang Cheng notified Advanced Biomed Inc. (the "Company") of his resignation as a member of the Board of Directors and as Chief Technology Officer of the Company, effective as of March 25, 2026.
Appointed: Mingze Yin, Director, effective 2026-03-25
On March 25, 2026, upon the recommendation of the Nominating Committee, the Board of Directors appointed Mingze Yin, the Chief Financial Officer of the Company, as a director of the Company, effective as of March 25, 2026.
- Mr. Cheng's resignation was not due to any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.
Tools for this story
Each opens in a new tab, filled in for Advanced Biomed Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.